AXL and cancer: Many cancer cells, including chronic lymphocytic leukemia (41), breast and prostate carcinomas (42, 43), and non-small cell lung cancers (44), show AXL-dependent PI3K/Akt signaling which drives proliferation, metastasis, invasion, and drug resistance.